TipRanks
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
UK Market
FAB
Fusion Antibodies Plc
RESEARCH TOOLSreports
Want to see GB:FAB full AI Analyst Report?

Fusion Antibodies Plc (FAB) Income Statement

10 Followers

Fusion Antibodies Plc Income Statement

Last quarter (Q4 2025), Fusion Antibodies Plc's total revenue was £1.27M, an increase of 113.78% from the same quarter last year. In Q4, Fusion Antibodies Plc's net income was £-637.00K. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
£ 2.11M£ 1.97M£ 1.14M£ 2.90M£ 4.80M
Gross Profit
£ 1.10M£ 430.00K£ -265.00K£ 202.00K£ 1.72M
Operating Expenses
£ 3.08M£ 2.21M£ 2.24M£ 3.04M£ 3.05M
Depreciation and Amortization
£ 127.00K£ 105.00K£ 220.00K£ 372.00K£ 751.00K
EBITDA
£ -1.85M£ -1.62M£ -2.06M£ -2.48M£ -573.00K
Operating Income
£ -1.98M£ -1.78M£ -2.29M£ -2.83M£ -1.33M
Other Income/Expenses
£ 832.00K£ 2.00K£ -1.00K£ -1.00K£ -8.00K
Pretax Income
£ -1.15M£ -1.78M£ -2.29M£ -2.86M£ -1.33M
Net Income
£ -1.15M£ -1.71M£ -2.23M£ -2.60M£ -1.20M
Per Share Metrics
Basic EPS
£ -0.01£ -0.02£ -0.04£ -0.10£ -0.05
Diluted EPS
£ -0.01£ -0.02£ -0.04£ -0.10£ -0.05
Weighted Average Shares Outstanding
 115.31M 95.88M 55.56M 26.01M 25.95M
Weighted Average Shares Outstanding (Diluted)
 115.31M 95.88M 55.56M 26.01M 25.95M
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History